Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5076
Standard BioTools
LAB
$280M
| $122K | ﹤0.01% |
63,379
+3,129
| +5% | +$6.18K |
|
|
ATRI
5077
DELISTED
Atrion Corp
ATRI
| $122K | ﹤0.01% |
215
| – | – |
|
|
CVLY
5078
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $122K | ﹤0.01% |
6,172
-1,378
| -18% | -$26.2K |
|
|
ACR
5079
ACRES Commercial Realty
ACR
$102M
| $121K | ﹤0.01% |
13,733
| – | – |
|
5080
Donegal Group Class A
DGICA
$696M
| $121K | ﹤0.01% |
8,370
-1,772
| -17% | -$26.2K |
|
5081
iShares Environmental Infrastructure and Industrials ETF
EFRA
$5.84M
| $121K | ﹤0.01% |
4,307
-1,213
| -22% | -$33.5K |
|
5082
Hamilton Beach Brands
HBB
$448M
| $121K | ﹤0.01% |
12,476
+476
| +4% | +$4.74K |
|
5083
NACCO Industries
NC
$322M
| $121K | ﹤0.01% |
3,510
+282
| +9% | +$9.64K |
|
|
ACCD
5084
DELISTED
Accolade Inc
ACCD
| $121K | ﹤0.01% |
8,995
+2,613
| +41% | +$33.9K |
|
5085
Amtech Systems
ASYS
$281M
| $120K | ﹤0.01% |
12,511
+3,911
| +45% | +$35.5K |
|
5086
Celularity
CELU
$20.1M
| $120K | ﹤0.01% |
22,500
-358
| -2% | -$2.29K |
|
5087
Torrid Holdings
CURV
$219M
| $120K | ﹤0.01% |
42,738
-109
| -0.3% | -$348 |
|
5088
iShares Currency Hedged MSCI Japan ETF
HEWJ
$766M
| $120K | ﹤0.01% |
3,555
-16,095
| -82% | -$498K |
|
5089
John Hancock Multifactor Small Cap ETF
JHSC
$749M
| $120K | ﹤0.01% |
3,582
-44,710
| -93% | -$1.42M |
|
5090
Rhythm Pharmaceuticals
RYTM
$7.95B
| $120K | ﹤0.01% |
7,249
+5,286
| +269% | +$95.4K |
|
5091
Angi Inc
ANGI
$191M
| $119K | ﹤0.01% |
3,614
+551
| +18% | +$15.4K |
|
|
CBL
5092
CBL Properties
CBL
$1.8B
| $119K | ﹤0.01% |
5,432
+524
| +11% | +$12.3K |
|
5093
PCB Bancorp
PCB
$399M
| $119K | ﹤0.01% |
8,049
-260
| -3% | -$3.71K |
|
|
RPT
5094
Rithm Property Trust
RPT
$104M
| $119K | ﹤0.01% |
3,238
-2,834
| -47% | -$102K |
|
5095
Canterbury Park Holding Corp
CPHC
$81M
| $118K | ﹤0.01% |
5,171
+1,871
| +57% | +$43.3K |
|
|
FGB
5096
DELISTED
First Trust Specialty Finance and Financial Opportunities Fund
FGB
| $118K | ﹤0.01% |
36,282
-55,548
| -60% | -$168K |
|
5097
VanEck India Growth Leaders ETF
GLIN
$92.9M
| $118K | ﹤0.01% |
3,220
-455
| -12% | -$15.4K |
|
5098
MeiraGTx Holdings
MGTX
$1.3B
| $118K | ﹤0.01% |
17,681
+5,940
| +51% | +$38.2K |
|
5099
MainStreet Bancshares
MNSB
$177M
| $118K | ﹤0.01% |
5,216
+1,591
| +44% | +$34.9K |
|
5100
Relay Therapeutics
RLAY
$4.35B
| $118K | ﹤0.01% |
9,420
+4,602
| +96% | +$57.2K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.